Inventor
SMITH CAMERON
US78 patents
⚠️ This page may combine multiple inventors who share the name “SMITH CAMERON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
20 patentsUS10196393B2Feb 5, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10392386B2Aug 27, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US10100049B2Oct 16, 2018
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US11634419B2Apr 25, 2023
Dimethyl amino azetidine amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US11254669B2Feb 22, 2022
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US10947229B2Mar 16, 2021
Dimethyl amino azetidine amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC10 citations84
US10836763B2Nov 17, 2020
5 to 7 membered heterocyclic amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC12 citations84
US11453668B2Sep 27, 2022
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11299492B2Apr 12, 2022
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US9725448B2Aug 8, 2017
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC1 citations63
US11878977B2Jan 23, 2024
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11667637B2Jun 6, 2023
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12398135B2Aug 26, 2025
Dimethyl amino azetidine amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations61
US11713315B2Aug 1, 2023
5 to 7 membered heterocyclic amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations61
ADOBE INC
7 patentsUS12327188B2Jun 10, 2025
Direct regression encoder architecture and training
ADOBE INC5 citations85
US11983628B2May 14, 2024
Attribute control techniques for image editing
ADOBE INC3 citations85
US11875221B2Jan 16, 2024
Attribute decorrelation techniques for image editing
ADOBE INC7 citations85
US12333427B2Jun 17, 2025
Multi-scale output techniques for generative adversarial networks
ADOBE INC3 citations84
US11880766B2Jan 23, 2024
Techniques for domain to domain projection using a generative model
ADOBE INC5 citations84
US12412089B2Sep 9, 2025
Supervised learning techniques for encoder training
ADOBE INC2 citations74
US11157773B2Oct 26, 2021
Image editing by a generative adversarial network using keypoints or segmentation masks constraints
ADOBE INC2 citations67
SMITH CAMERON
3 patentsSMITH WILLIAM
3 patentsFLEURY MELISSA
2 patentsBLUE COAT SYSTEMS INC
2 patentsHVR MSO LLC
2 patentsGM GLOBAL TECH OPERATIONS LLC
2 patentsGOODMAN JAMES P
2 patentsTHERAVANCE INC
1 patentMERCK SHARP & DOHME
1 patentCLUB GLIDER HOLDINGS LLC
1 patentTONG LUCAS
1 patentADVANCED BIONICS AG
1 patentTHRIVAL LLC
1 patentHUSFELD CRAIG
1 patentShowing the top 50 of 78 patents by PatentIndex Score.